Importantly, most GLP-1 receptor agonists carry a boxed warning about the risk of thyroid C-cell tumors and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Serious side effects reported include: Long-Term Effects and Concerns: Research links long-term GLP-1 agonist use with increased risk of gallbladder and biliary diseases, and concern remains about other serious adverse reactions that patients may not be warned about
Petanjek Z, Juda M, imic G, Rasin MR, Uylings HBM, Rakic P, et al
When it comes to unapproved peptides like BPC-157, he has made an additional argument: These substances are already on the gray market, raising the risk that someone may be harmed by a mislabeled or contaminated product
Did you know that in order to go under general anesthesia, you must stop taking Ozempic and all other GLP-1 medications 2 weeks beforehand